Filing Details

Accession Number:
0001140361-11-029093
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-05-20 16:30:27
Reporting Period:
2011-05-18
Filing Date:
2011-05-20
Accepted Time:
2011-05-20 16:30:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1228627 Rexahn Pharmaceuticals Inc. RNN Pharmaceutical Preparations (2834) 113516358
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1316420 Ho Chang Ahn C/O Rexahn Pharmaceuticals, Inc.
15245 Shady Grove Road, Suite 455
Rockville MD 20850
Chairman & Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-05-18 1,008,078 $1.31 11,338,924 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 500,000 Indirect Owned by spouse
Footnotes
  1. On May 18, 2011, the reporting person acquired 1,008,078 shares from a family trust in full satisfaction of an existing indebtedness of that trust to the reporting person in the amount of $1,320,581.86. A third party is the trustee of the trust, and the reporting person does not have any voting or dispositive power with respect to the shares held by the trust.
  2. Includes 500,000 shares owned by the reporting person's wife, as to which the reporting person disclaims beneficial ownership.